NCT05426915View on ClinicalTrials.gov

Clinical Study for the Effectiveness of Roflumilast Treatment in COPD Greek Patients Based on Standard Clinical Practice.

UnknownOBSERVATIONAL
Enrollment

750

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

May 1, 2024

Study Completion Date

May 1, 2024

Conditions
CopdCOPD Exacerbation
Trial Locations (1)

Unknown

RECRUITING

Sotiria Hospital, Athens

Sponsors
All Listed Sponsors
lead

Elpen Pharmaceutical Co. Inc.

INDUSTRY